Mito Metabolic Optimization 3X

Description

The Mito Metabolic Optimization 3X Research Kit combines MOTS-c (40mg), 5-Amino-1MQ (50mg), and Cagrilintide (10mg) — addressing mitochondria-to-nucleus signaling, NNMT-mediated NAD⁺ conservation, and long-acting amylin receptor activation in a three-pathway metabolic research panel.

Kit Components

• MOTS-c (40mg): Mitochondria-derived peptide activating AMPK and ARE/Nrf2 nuclear gene programs. Improves insulin sensitivity and mitochondrial function. Levels decline in aging and metabolic disease.
• 5-Amino-1MQ (50mg): NNMT inhibitor that conserves the SAM pool, shifts NAD⁺/NADH ratios, and reduces adipocyte lipid accumulation in cell models.
• Cagrilintide (10mg): Long-acting amylin analogue activating hypothalamic AMY receptors for sustained satiety signaling and gastric emptying modulation.

Research Context

This kit investigates metabolic optimization from both the cellular bioenergetics angle (MOTS-c, 5-Amino-1MQ) and the systemic hormonal regulation angle (Cagrilintide). MOTS-c and 5-Amino-1MQ both intersect at NAD⁺ metabolism — MOTS-c activates NAD⁺ biosynthesis via AMPK, while 5-Amino-1MQ reduces NNMT-mediated NAD⁺ metabolite consumption. Cagrilintide adds the peripheral hormonal satiety dimension.

Common Research Applications

• Mitochondrial bioenergetics + satiety hormone combination studies
• AMPK-NNMT-NAD⁺ pathway interaction research
• Multi-mechanism metabolic syndrome investigation
• Cellular energy optimization + appetite regulation studies

For Research Use Only. Not for human or veterinary use.